Key result
Heart transplantation yields stable graft function at ~6 years in Becker muscular dystrophy.
Why the study?
Pathogenic variants in the DMD gene are a frequently overlooked cause of dilated cardiomyopathy in idiopathic cases, particularly when skeletal myopathy is mild or seemingly absent.
Does orthotopic heart transplantation improve outcomes in a patient with end-stage dilated cardiomyopathy secondary to unrecognized Becker muscular dystrophy?
Case Report (n=1)
No
Does orthotopic heart transplantation improve outcomes in a patient with end-stage dilated cardiomyopathy secondary to unrecognized Becker muscular dystrophy?
Heart transplantation is a viable option for end-stage heart failure in Becker muscular dystrophy, highlighting the critical importance of considering dystrophinopathies in cases of apparently idiopathic dilated cardiomyopathy.
Supports transplantation consideration in selected Becker muscular dystrophy; leaves open genetic screening utility in idiopathic dilated cardiomyopathy.
Background: Pathogenic variants in the DMD gene are a frequently overlooked cause of dilated cardiomyopathy (DCM) in idiopathic cases, especially when skeletal myopathy is mild or seemingly absent. Becker muscular dystrophy (BMD) and X-linked dilated cardiomyopathy are at opposite ends of this clinical spectrum but result from pathogenic variants in the same gene. Cardiomyopathy is a major cause of premature death in muscular dystrophies. Case presentation: We describe a 37-year-old man who underwent orthotopic heart transplantation for presumed idiopathic DCM with refractory heart failure. He had a six-year history of progressive proximal weakness, pseudohypertrophy of the calf, a positive Gowers sign, and markedly elevated creatine kinase (6638 IU/L). Multiplex ligation-dependent probe amplification (MLPA) revealed an in-frame deletion of exons 45–47 of DMD [c. (6438+1_6439-1)_(6912+1_6913-1) del; NM_004006.2], confirming BMD. Immunofluorescence showed reduced and patchy dystrophin expression. Conclusions: To our knowledge, this is the first documented heart transplant in a patient with BMD in Mexico. This case demonstrates the value of considering muscular dystrophy in the differential diagnosis of apparently idiopathic dilated cardiomyopathy (DCM), a step that opens the door to accurate diagnosis, carrier screening, and genetic counseling, and supports the view that heart transplantation is a viable option in carefully selected patients with muscular dystrophy cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Vázquez-Cárdenas et al. (2026) conducted a case report in Becker muscular dystrophy and dilated cardiomyopathy (n=1). Orthotopic heart transplantation was evaluated on Graft function and survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: